Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?

por Wish, Jay B.
Publicado 2023

Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?

por Wish, Jay B.
Publicado 2019

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?

por Wish, Jay B.
Publicado 2020

Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors for the Treatment of Anemia in CKD: Additional Pieces of the Jigsaw Puzzle

por Wish, Jay B.
Publicado 2021

Treatment of Anemia in Kidney Disease: Beyond Erythropoietin

por Wish, Jay B.
Publicado 2021

Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus

por Wish, Jay B., Pergola, Pablo
Publicado 2022

Balancing Nephrology Referrals With Nephrologist Capacity to Decrease Emergency Dialysis Starts

por Jan, M. Yahya, Wish, Jay B.
Publicado 2020

Past, Present, and Future of Phosphate Management

por Doshi, Simit M., Wish, Jay B.
Publicado 2022

Kidney disease and congenital heart disease: Partnership for life

por El Sayegh, Skye, Ephrem, Georges, Wish, Jay B., Moe, Sharon, Lim, Kenneth
Publicado 2022

Recovery of Renal Function among ESRD Patients in the US Medicare Program

por Mohan, Sumit, Huff, Edwin, Wish, Jay, Lilly, Michael, Chen, Shu-Cheng, McClellan, William M.
Publicado 2013

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective

por Aapro, Matti, Gascón, Pere, Patel, Kashyap, Rodgers, George M., Fung, Selwyn, Arantes, Luiz H., Wish, Jay
Publicado 2019

Iron Deficiency in CKD Without Concomitant Anemia

por Wish, Jay B., Anker, Stefan D., Butler, Javed, Cases, Aleix, Stack, Austin G., Macdougall, Iain C.
Publicado 2021

Improving the Care of ESRD Patients: A Success Story

por McClellan, William M., Frankenfield, Diane L., Frederick, Pamela R., Helgerson, Steven D., Wish, Jay B., Sugarman, Jonathan R.
Publicado 2003

Long-term Safety of Epoetin Alfa-epbx for the Treatment of Anemia in ESKD: Pooled Analyses of Randomized and Open-label Studies

por Wish, Jay B., Rocha, Marcelo G., Martin, Nancy E., Reyes, Christian Russel D., Fishbane, Steven, Smith, Mark T., Nassar, George
Publicado 2019

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk

por Ganz, Tomas, Aronoff, George R., Gaillard, Carlo A.J.M., Goodnough, Lawrence T., Macdougall, Iain C., Mayer, Gert, Porto, Graça, Winkelmayer, Wolfgang C., Wish, Jay B.
Publicado 2020

Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey

por Michalopoulos, Steven N., Gauthier-Loiselle, Marjolaine, Aigbogun, Myrlene Sanon, Serra, Elizabeth, Bungay, Rebecca, Clynes, Diana, Cloutier, Martin, Kahle, Erin, Guérin, Annie, Farag, Youssef M.K., Wish, Jay B.
Publicado 2022